Shan Fu
Non-Executive DirectorMr. Shan Fu, M.A., is Director of Sinovac Biotech Ltd. from July 8, 2025. He had been an Independent Director of Sinovac Biotech Ltd. since July 2018. He is a Non-Executive Director at Genetron Holdings Limited since June 30, 2021. He serves as Managing Partner at Vivo Capital, LLC. He was Partner, Managing Partner, Co-CEO and CEO of Asia Pacific. Mr. Fu joined Vivo in 2013. Before joining Vivo, Mr. Fu was the Chief Representative of Beijing at The Blackstone Group L.P., since August 2008 and Senior Managing Director at Private Equity Segment since January 1, 2011. He is Non-Executive Director at VISEN Pharmaceuticals and serves as Chairman of the board since June 27, 2025. Mr. Fu served as the Director at New Frontier Health Corporation (formerly known as New Frontier Corporation) since December 19, 2019. He serves as a board of directors at Esco Micro Pte. Ltd. He is Director of Provivi Inc. from December 22, 2020. Mr. Fu served as Director at BioDlink International Company Limited (formerly known as TOT BIOPHARM International Company Limited) since January 19, 2016 until April 29, 2026 and served as its Executive Chairperson of the Board since October 11, 2025 until April 29, 2026. He has been Non-Executive Director at Lepu Scientech Medical Technology (Shanghai) Co., Ltd. since June 9, 2021. He was the Chairperson of the Board at BioDlink International Company Limited (formerly known as TOT BIOPHARM International Company Limited) since September 28, 2018 until October 11, 2025. He joined BioDlink International Company Limited (formerly known as TOT BIOPHARM International Company Limited) on January 19, 2016. Mr. Fu served as a Principal at The Blackstone Group L.P., Managing Director of Corporate Private Equity, Chief Representative of Beijing Office since 2008 until 2013. He served as a Vice President at Beijing Mainstreets Investment Group. Mr. Fu served at the Department of Foreign Investment in China's National Development and Reform Commission (NDRC), the State Economic and Trade Commission of China since 2003 until 2008, the Office of Economic and Trade in State Council of China and the Office of Production of the State Council of China since 1993 until 2003. He had been a Director of Innocare Pharma Ltd. since February 5, 2018 until March 27, 2023 and was re-designated as a Non-executive Director on September 27, 2019. He serves as Non-Executive Director at VISEN Pharmaceuticals (Shanghai) Co., Ltd. Since March 27, 2021 and served as its Director since November 01, 2018. He has been the director of VISEN HK since November 2018, the director of VISEN BVI since November 2020 and the director of VISEN Suzhou since June 2021. He served as a Non-Executive Director of China Animal Healthcare Ltd. from August 20, 2010 to November 22, 2013. He was recognized amongst "Top 20 China's Best Investors in the Health Care Industry" by CVInfo in 2021. He was recognized amongst "Top 100 Best Venture Investors in China" by CVInfo in 2021. Mr. Fu has done a Masters in History in July 1991 and a Bachelor of Arts degree in History in July 1988 from Peking University in Beijing, China.
Positions
- Company NameLEPU ScienTech Medical Technology (Shanghai) Co., Ltd.Stock Code02291PositionNon-Executive DirectorColleagues
- JCJuan ChenExecutive Chairman & GM
- XQXue QinDeputy GM & CFO
- YHYufeng HeDeputy GM & COO
- XZXiani ZhangDeputy General Manager
- KQKejin QiuHead of Research & Development of Valve Division
- YZYufeng ZhengIndependent Non-Executive Director
- KLKa Lai ChanIndependent Non-Executive Director
- YZYuxin ZhangNon-Executive Director
- Company NameVISEN PharmaceuticalsStock Code02561PositionNon-Executive ChairmanColleagues
